 NEW YORK, Sept. 27, 2021 GLOBE NEWSWIRE -- Immunovant, Inc. Nasdaq: IMVT, a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases, today announced that Pete Salzmann, M.D., Chief Executive Officer, will participate in a fireside chat during Roivant RD Day 2021 on Tuesday, September 28, 2021 at 4:00 p.m. ET. 